Skip to main content
. 2020 Oct 30;83(Supple 1):S46–S54. doi: 10.4046/trd.2020.0095

Table 4.

Laboratory value risk factors associated with mortality

Univariate analysis
Multivariate analysis
OR 95% CI p-value OR 95% CI p-value
Hematological and inflammation-related indices
 White-cell count (≥12×103/µL vs. <12×103/µL) 4.23 2.29–7.84 <0.001 - - -
 Neutrophil count (≥10×103/µL vs. <10×103/µL) 4.68 2.51–8.71 <0.001 - - -
 Neutrophil-to-lymphocyte ratio (≥9 vs. <9) 5.69 3.01–10.76 <0.001 4.64 2.05–10.53 <0.001
 Procalcitonin (≥0.5 ng/mL vs. <0.5 ng/mL) 6.16 3.13–12.09 <0.001 - - -
 CRP (≥150 mg/L vs. <150 mg/L) 1.85 1.03–3.35 0.041 - - -
 Lymphocyte-to-CRP (<6 vs. ≥6) 0.97 0.95–0.99 0.013 - - -
Coagulation factors
 D-dimer baseline (≥700 ng/mL vs. <700 ng/mL) 2.64 1.44–4.84 0.002 - - -
 D-dimer day 3 (≥1,000 ng/mL vs. <1,000 ng/mL) 4.69 2.28–9.65 <0.001 - - -
Organ-injury biochemical biomarkers
 Glucose (≥130 mg/dL vs. <130 mg/dL) 2.58 1.42–4.72 0.002 - - -
 Protein level (<6.5 g/dL vs. ≥6.5 g/dL) 5.04 2.43–10.47 <0.001 - - -
 Serum albumin (<3.5g/dL vs. ≥3.5 g/dL) 4.62 2.14–9.95 <0.001 3.76 1.56–9.07 0.003
 Troponin T (≥10 pg/mL vs. <10 pg/mL) 6.30 3.30–12.05 <0.001 - - -
 CK-MB (≥25 U/L vs. <25 U/L) 3.17 1.72–5.83 <0.001 - - -
 LDH (≥725 U/L vs. <725 U/L) 5.85 3.03–11.27 0.004 5.45 2.36–12.57 <0.001

OR: odds ratio; CI: confidence interval; CRP: C-reactive protein; CK-MB: creatine kinase mb fraction; LDH: lactate dehydrogenase.